Whether newly USFDA released or second-life generics, EarlyHealth ensures that our customers penetrate the right markets for the well-being of the patients unmet needs.
If you are interested to assign products for exclusive distribution, whether as unlicensed or registered for distribution, contact our Market Access team and see how we can maximize return on your asset, whilst benefiting those patients is need of treatments locally not available.
Below is our portfolio of exclusive product distribution rights of various markets in Europe, Latin America and Middle East. For more information on how to access these products, contact us today.
